Selecting here opens the current stored cards. The pinned link below records their fingerprints. Do not enter patient information in links or searches.
Share or print this source review
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Copy is optional; the link can be selected and copied manually. No patient data or dose decision is collected.
Clinical context remains essential
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The official product label and its RX mirror are one underlying evidence family, not two independent clinical validations. Confirm the current exact product label before prescribing.
Selected renal sections summarized locally. Not a complete monograph or independent clinical approval.
Documented differences and cautions on this drug
All record notes are retained here, including notes about sources not selected in this review.
Before use: Dorzolamide 2% ophthalmic solution (Trusopt)
Historical label retained as a dated renal restriction; current marketed-product reconciliation is pending.
What to reconcile: Check the current exact ophthalmic product and renal status. Do not substitute the timolol combination or infer a dialysis schedule.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding
Check the current exact ophthalmic product and renal status. Do not substitute the timolol combination or infer a dialysis schedule.
Dialysis evidence: No dialysis regimen established in selected content
Selected renal sections summarized locally. Not a complete monograph or independent clinical approval.
Renal guidance and important limits
Limits that apply to these rows
Topical administration can produce systemic exposure and sulfonamide reactions. Concomitant oral carbonic-anhydrase inhibitors are not recommended because effects may be additive.
Historical FDA 2020 supplement: current exact marketed-product labeling remains to be reconciled. This entry is not a claim of current-label approval.
Not recommended. Severe impairment was not studied, and parent drug/metabolite are predominantly renally eliminated.
Other renal bands / renal replacement therapy
No additional renal dose schedule is established by this selected summary; absence of a row is not evidence of safety.
Read the retained text before reformatting
Renal setting
Source-specific action and limits
CrCl <30 mL/min
Not recommended. Severe impairment was not studied, and parent drug/metabolite are predominantly renally eliminated.
Other renal bands / renal replacement therapy
No additional renal dose schedule is established by this selected summary; absence of a row is not evidence of safety.
Topical administration can produce systemic exposure and sulfonamide reactions. Concomitant oral carbonic-anhydrase inhibitors are not recommended because effects may be additive.
Historical FDA 2020 supplement: current exact marketed-product labeling remains to be reconciled. This entry is not a claim of current-label approval.
The official product label and its RX mirror are one underlying evidence family, not two independent clinical validations. Confirm the current exact product label before prescribing.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
GlobalRPh Renal Dosing Master v6.8. Review the retrieval and revision dates attached to each source. Selecting a reference does not imply clinical verification.